Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Vimian Group AB ( (SE:VIMIAN) ).
Vimian Group AB has announced the acquisition of AllAccem Inc., a leading provider of veterinary dental sealant products in the US, as part of its strategy to enhance its veterinary dental offerings. This acquisition, which will integrate AllAccem into Vimian’s MedTech segment, is expected to bolster Vimian’s position in the fast-growing niche of animal dental health, leveraging AllAccem’s high-margin products and strong market presence to improve global animal dental care.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company that operates in four key areas: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Based in Stockholm, Sweden, the company aims to provide innovative care solutions for animals, reaching over 17,000 veterinary clinics and laboratories across more than 80 markets.
Average Trading Volume: 444,717
Current Market Cap: SEK22.7B
Find detailed analytics on VIMIAN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue